Tennor Therapeutics (Suzhou) Limited

Chine

Commandez votre montre hebdomadaire Tennor Therapeutics (Suzhou) Limited
Quantité totale PI 21
Rang # Quantité totale PI 72 094
Note d'activité PI 2,4/5.0    30
Rang # Activité PI 25 581

Brevets

Marques

6 0
0 0
15 0
0
 
Dernier brevet 2025 - Solid dispersion of compound and...
Premier brevet 2005 - Rifamycin imino derivatives effe...

Derniers inventions, produits et services

2025 Invention Solid dispersion of compound and use thereof. Disclosed is a solid dispersion of a rifamycin-quin...
Invention Use of compound for preparing drug for treating bacterial metabolism-related diseases. 144) quino...
2024 Invention Crystal form of compound and use thereof. The present application provides crystal forms A and B ...
Invention Salts of compounds, crystal forms thereof, preparation method therefor and use thereof. Provided ...
2023 Invention Use of compound in preparation of drug for treatment or prevention of mycobacterium tuberculosis ...
Invention Pharmaceutical composition comprising sulbactam and avibactam, and application thereof. The pres...
Invention Rifamycin-quinolizinone coupled molecule ointment and method for preparing same. Provided is a ri...
Invention H. pylori infection. H. pylori) infection in a patient in need thereof.
Invention Method and use of compound for treating diseases. Provided in the present application is a method...
Invention Method of treating disease using compound, and use of compound. Provided in the present applicati...
Invention Joint cavity drug administration method, and use thereof. The present application provides a meth...
Invention Method for treating prosthetic joint infection by using compound. Provided in the present applica...
Invention Method for preventing prosthetic joint infection by using compound. The present application provi...
2022 Invention Pharmaceutical composition comprising sulbactam and avibactam, and application thereof. The prese...
Invention Methods for preventing or treating h. pylori infection. The present disclosure provides methods, ...
2020 Invention Penam derivatives for treating bacterial infections. Novel iron chelating group conjugated penam ...
2019 Invention Use of rifamycin-nitroimidazole coupling molecule. The present invention provides a use of a rif...
Invention Use of rifamycin-quinolizidone coupling molecule. The present invention provides a use of a rifa...
2018 Invention Antibacterial pharmaceutical combination and method for treating gram-negative bacteria infection...
2017 Invention Anti-microbial composition for treating gram-negative bacterial infection. The present invention ...
2009 Invention Bicyclic nitroimidazole-substituted phenyl oxazolidinones. Mycobacterium tuberculosis.
2008 Invention Quinolone carboxylic acid-substituted rifamycin derivatives. The compounds include substituted ri...
2007 Invention Nitroheteroaryl-containing rifamycin derivatives. Substituted rifamycin derivatives in which a ni...
2005 Invention Rifamycin derivatives. 4) forms): wherein: a preferred R comprises hydrogen, acetyl; L is a lin...
Invention (r/s) rifamycin derivatives, their preparations and pharmaceutical compositions. 4) forms): 2 co...
Invention Spiro-rifamycin derivatives targeting rna polymerase. Compounds of the current invention relate t...
Invention C-25 carbamate rifamycin derivatives with activity against drug-resistant microbes. Compounds of ...
Invention Rifamycin derivatives effective against drug-resistant microbes. Rifamycin derivatives having ant...
Invention Rifamycin imino derivatives effective against drug-resistant microbes. The present invention rela...